It seems like a tough sell for musical theater, but the opening night performance of Martin Shkreli's Game played to a sold out crowd of 65 at the Midtown International Theatre Festival in New York on Tuesday. To refresh your memory Shkreli, a former pharma executive, came…

Research incentives from governments including the US, Britain and China have pharmaceutical giants reigniting their efforts to develop new antibiotics. Until recently, companies had abandoned researching and testing antibiotics because of high expense and low profit.…

By the end of June, the most effective African anti-venom, deemed unprofitable, is set to run out. Drugmaker Sanofi-Pasteur has ceased production, citing the commercial disadvantages of the treatment—time-consuming to produce and expensive, at a cost of about $500 for…

The pharmaceutical industry stands out as particularly corruption-prone, according to a new report from watchdog agency Transparency International—but the media doesn’t pay notice, writes Roy Poses, a clinical associate professor of medicine at Brown University. The report…

Sky-high prices put two widely used hepatitis C treatments beyond the reach of people in many poor countries, creating a “financial and ethical dilemma” for payers and doctors, according to a new PLOS Medicine study by WHO officials.  Studying 2015 prices for the Sovaldi…

Many who opposed passage of the Trans-Pacific Partnership (TPP) cited concerns that the agreement would drive up drug prices and a shift away from cheaper generics in US trade partner countries.

Doctors have long disputed that the payments they receive from pharmaceutical companies have any relationship to how they prescribe drugs. There’s been little evidence to settle the matter—until now. A ProPublica analysis has found that doctors who received money from drug…

While no one disputes the need for timelier access to medicines in humanitarian emergencies, pharmaceutical company donations stir debate. In Syria, for example, several major drug companies have donated medicines to NGOs like the International Committee of the Red Cross,…

In Africa, many countries lack regulatory systems able to detect poor-quality or counterfeit medicines and yank them from the shelves. For example, an estimated 90% of the oxytocin on the market in Ghana was found to be substandard, according to Patrick Lukulay, a VP at…

As an opioid epidemic sweeps the US, pharmacists are in an especially tough position, pulled between patients in dire need of relief and addicts who will stop at nothing to get drugs. The expectation that they act as watchdogs has sent ripples of controversy among the…